Your session is about to expire
← Back to Search
Behavioral Intervention
Deaf Weight Wise Intervention for Obesity
N/A
Waitlist Available
Led By Steven L Barnett, MD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 18 and older
Are Ages 18 and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at each site at 18 months after baseline enrollment of participants
Awards & highlights
Study Summary
This trial will study how well different organizations can implement an evidence-based healthy lifestyle intervention for deaf adults who use American Sign Language.
Who is the study for?
This trial is for Deaf adults who use American Sign Language and live in Buffalo, Rochester, or Syracuse, NY. Participants must be 18+, have a BMI of at least 18.5, and get healthcare provider approval if they have certain health conditions. They should be willing to eat healthily, avoid weight loss drugs, attend group sessions, and participate in data collection.Check my eligibility
What is being tested?
The study tests the implementation of 'Deaf Weight Wise', a program designed to promote healthy lifestyles among Deaf ASL users. It examines how different community organizations can successfully apply this evidence-based intervention with their members.See study design
What are the potential side effects?
Since this is a lifestyle intervention focusing on diet and exercise rather than medication or medical procedures, typical side effects associated with drugs are not expected. However, participants may experience general discomforts related to changes in diet or physical activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at each site at 18 months after baseline enrollment of participants
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at each site at 18 months after baseline enrollment of participants
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Site-level outcome: Implementation of the Deaf Weight Wise intervention at partner sites
Site-level outcome: Percentage of Deaf Weight Wise intervention groups delivered as intended
Secondary outcome measures
Participant-level outcome: Mean change from baseline to 6-months (post-intervention) in number of fruit and vegetable servings per day as measured by the Block fruit, vegetable, fiber screener
Participant-level outcome: Mean change from baseline to 6-months (post-intervention) in physical activity as reported on the International Physical Activity Question (IPAQ)
Participant-level outcome: Mean change from baseline to 6-months (post-intervention) in self-reported body weight, for participants with BMI above normal range
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single Intervention Arm (Main Intervention)Experimental Treatment1 Intervention
Main Intervention
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
845 Previous Clinical Trials
534,932 Total Patients Enrolled
11 Trials studying Obesity
6,697 Patients Enrolled for Obesity
Steven L Barnett, MDPrincipal InvestigatorUniversity of Rochester
1 Previous Clinical Trials
76 Total Patients Enrolled
1 Trials studying Obesity
76 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to follow a healthy diet, avoid weight loss drugs, attend group sessions, and participate in data collection for the study.I am willing to follow a healthy diet, avoid weight loss drugs, attend group sessions, and participate in data collection for the study.I am 18 years old or older.Your body weight is within a healthy range for your height.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Single Intervention Arm (Main Intervention)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger